Gsk (GSK) Income from Discontinued Operations (2021 - 2022)
Gsk (GSK) posted Income from Discontinued Operations of $12.6 billion for Q4 2022, up 5.64% quarter-over-quarter from $11.9 billion in Q3 2022, and up 489.26% YoY from $2.1 billion in Q4 2021.
Powered by 
Analysis
Gsk (GSK) Income from Discontinued Operations (2021 - 2022) Analysis & Trends
Gsk (GSK) has 2 years of Income from Discontinued Operations data on file, last reported at $12.6 billion in Q4 2022.
- For the quarter ending Q4 2022, Income from Discontinued Operations rose 489.26% year-over-year to $12.6 billion; the trailing twelve-month figure through Dec 2022 stood at $25.2 billion (up 599.41% YoY), and the FY2022 full-year result was $13.2 billion, up 509.16% from the prior year.
- Income from Discontinued Operations was $12.6 billion for Q4 2022 at Gsk, up from $11.9 billion in the prior quarter.
- In the past five years, Income from Discontinued Operations ranged from a high of $12.6 billion in Q4 2022 to a low of $288.4 million in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Asml Holding | 619.91 Bn | 603.93 Bn | 5.90 Bn | - |
| 2 | Hsbc Holdings | 362.69 Bn | 362.69 Bn | - | - |
| 3 | General Electric | 329.36 Bn | 320.01 Bn | 6.95 Bn | -38.00 Mn |
| 4 | Astrazeneca | 254.01 Bn | 248.73 Bn | 12.86 Bn | - |
| 5 | Citigroup | 228.33 Bn | -2,073.98 Bn | 24.75 Bn | - |
| 6 | Bhp | 215.97 Bn | 197.42 Bn | - | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - | - |
| 8 | Diageo | 197.54 Bn | 195.50 Bn | - | - |
| 9 | Unilever | 139.09 Bn | 132.06 Bn | - | - |
| 10 | Gsk | 101.58 Bn | 101.58 Bn | 15.97 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 12.55 Bn |
| Sep 30, 2022 | 11.88 Bn |
| Jun 30, 2022 | 288.38 Mn |
| Mar 31, 2022 | 531.37 Mn |
| Dec 31, 2021 | 2.13 Bn |
| Sep 30, 2021 | 581.76 Mn |
| Jun 30, 2021 | 373.19 Mn |
| Mar 31, 2021 | 525.37 Mn |